Supernus Pharmaceuticals (SUPN) Asset Utilization Ratio (2012 - 2025)

Supernus Pharmaceuticals (SUPN) has 14 years of Asset Utilization Ratio data on file, last reported at 0.5 in Q4 2025.

• On a quarterly basis, Asset Utilization Ratio rose 2.52% year-over-year to 0.5 in Q4 2025; TTM through Dec 2025 was 0.5, a 2.52% increase from a year earlier, with the FY2025 full-year figure at 0.51, up 1.89% from the prior year.
• Asset Utilization Ratio for Q4 2025 stood at 0.5, up from 0.49 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for SUPN reached as high as 0.5 in Q4 2025 and fell as low as 0.35 in Q1 2021.
• Historically, Asset Utilization Ratio has averaged 0.43 across 5 years, with a median of 0.44 in 2023.
• Across the five-year window, Asset Utilization Ratio slumped 39.81% in 2021 and increased 21.75% in 2023, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.36 in 2021, then rose by 9.95% to 0.39 in 2022, then increased by 20.64% to 0.47 in 2023, then grew by 2.99% to 0.49 in 2024, then grew by 2.52% to 0.5 in 2025.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.5 in Q4 2025, 0.49 in Q3 2025, and 0.49 in Q2 2025.